New Game Changers In Medicine Episode About The Discovery Of Insulin Premieres On World Diabetes Day, November 14
NEW YORK, Nov. 12, 2020 /PRNewswire/ — Game Changers in Medicine, the new monthly podcast from Dramatic Health, premieres its fifth episode “Insulin: The lucky coin toss and improbable partnership that led to this life-saving elixir“ on World Diabetes Day, November 14, 2020. Insulin was discovered almost 100 years ago and has been saving the lives of patients with diabetes ever since. Currently, more than 460 million people worldwide suffer from some form of diabetes. Produced by Dramatic Health co-founder and CEO Sean T. Moloney, the series is hosted by renowned medical futurist Dr. Rubin Pillay of the University of Alabama at Birmingham (UAB).
For details on the podcast series, visit www.gamechangersinmedicine.com
The Dramatic Health and Game Changers in Medicine teams have gathered a distinguished group of experts to discuss the science and serendipity behind the discovery of insulin, and to offer their perspectives on the ongoing search for a cure for diabetes. Participants in “Insulin: The lucky coin toss and improbable partnership that led to this life-saving elixir“ include: Jay S. Skyler, MD, MACP is currently a Professor of Medicine, Pediatrics, & Psychology, in the Division of Endocrinology, Diabetes & Metabolism, Department of Medicine, University of Miami Leonard M. Miller School of Medicine. He served as Director of that division from 2000 to 2004. He is Deputy Director of Clinical Research and Academic Programs at the Diabetes Research Institute. Grant Maltman, curator of the Banting House National Historic Site of Canada, in London, Ontario, coordinates cultural resource management and heritage presentation at Banting House–the birthplace of insulin. Toby Smithson, MS, RDN, CDE is a registered dietitian nutritionist (RDN) and certified diabetes educator (CDE) who has successfully managed her own Type 1 diabetes for more than 45 years.
According to Executive Producer Sean Moloney, “We have an abundance of material, including an interview with Dr. H. Franklin Bunn, the hematologist at Harvard Medical School, who co-discovered the hemoglobin A1c, a major diagnostic indicator of prediabetes and diabetes. Dr. Bunn appeared in the premiere episode of Game Changers in Medicine last July.” A bonus episode of “Insulin: The lucky coin toss and improbable partnership that led to this life-saving elixir“ will be released at the end of November.
Dramatic Health, a national healthcare video company, is the producer of the six-part podcast series Game Changers in Medicine. Previous episodes have included: the premiere podcast about Vitamin K and an enterprising Boston house doctor; the creation of a smallpox vaccine and its parallels to today’s urgent search for a COVID-19 vaccine; the history of the blood thinner warfarin, a rat poison turned game-changer in cardiology, and the development of the X-ray. All episodes, a series backgrounder, and additional material about the podcast series are available at www.gamechangersinmedicine.com and can be accessed wherever you find your podcasts.
Contact: Mark G. Auerbach. [email protected]
For additional details on the episode participants:
Diabetes Research Institute Foundation.
Harrington Discovery Institute At University Hospitals And Case Western Reserve School Of Medicine Open Call For 2021 Harrington-MSTP Scholar Award
CLEVELAND, Nov. 10, 2020 /PRNewswire/ — Harrington Discovery Institute at University Hospitals and Case Western Reserve University School of Medicine have issued a call for proposals for the 2021 Harrington-MSTP (Medical Scientist Training Program) Scholar Award to help the next generation of physician-scientists advance their discoveries into breakthrough medicines. This program is a two-year scholarship for MSTP students at the School of Medicine whose work has been identified as innovative, creative and having potential to progress towards clinical application.
Since its founding in 2012, Harrington Discovery Institute–part of The Harrington Project for Discovery & Development–has supported 137 drugs-in-the-making in the US, Canada and the United Kingdom. Core to its mission, Harrington Discovery Institute recognizes and supports inventive physician-scientists through dedicated programs, including the global Harrington Prize (partnered with The American Society for Clinical Investigation), North American Scholar-Innovator Award, and the Cleveland, Ohio-based Harrington Investigator programs. With this program, now in its second year, the Institute has expanded its model to include the next generation of physician-scientists early in their career.
Through this award, Harrington Discovery Institute and the School of Medicine combine resources and capabilities to advance into new medicines the most promising research of Case MSTP students. Awardees will receive grant funding and dedicated therapeutic development support from Harrington Discovery Institute’s Therapeutics Development team, who are pharma-experienced industry leaders with a track record of bringing drugs to market.
“We are committed to helping physician-scientists improve the standard of care and address unmet needs in healthcare through their research. This program helps students take promising scientific discoveries and chart a path forward that maximizes potential for clinical success. Now more than ever, it is essential that we help close the gap between breakthroughs in the lab and much-needed treatments for patients. We are pleased to work closely with Case Western Reserve University to provide this opportunity,” said Jonathan S. Stamler, MD, President, Harrington Discovery Institute, Robert S. and Sylvia K. Reitman Family Foundation Distinguished Chair of Cardiovascular Innovation and Professor of Medicine at University Hospitals and Case Western Reserve University.
“This program provides tremendous value for the students selected, which they will carry with them throughout their careers. In working with former pharma executives, awardees are able to build new skills and gain a broader understanding of their research in relation to industry. The Case MSTP program has always focused on cultivating an innovation mindset with our students and providing them with the tools necessary for a successful career,” said Derek Abbott, MD, PhD, Program Director, Medical Scientist Training Program, Case Western Reserve School of Medicine.
Interested applicants from Case Western Reserve University’s MSTP program are asked to submit a Letter of Intent by December 7, 2020. Up to two award recipients will be selected and announced in spring 2021. For more information, visit: HarringtonDiscovery.org/MSTP.
Harrington Discovery Institute
The Harrington Discovery Institute at University Hospitals in Cleveland, OH — part of The Harrington Project for Discovery & Development — aims to advance